Shabir Madhi
latest news & developments
Covid-19 in South Africa: Which approach should we take now?
The trick to tackling Covid-19 at this stage is to be adaptive. The government’s one-size-fits-all approach is broken; we need to be more flexible. But we should not throw away…
Omicron variant of Covid the dominant strain in South Africa
It’s time to get vaccinated because the Covid viral firestorm is spreading fast
South Africa opens up vaccinations for 12 to 17 year-olds
Vaccinology researcher Professor Shabir Madhi said young people were being vaccinated to reduce the number of people who could transmit the virus and the focus should instead be…
What we know about the C.1.2 Covid variant, so far
Experts studying the new variant, C.1.2, are surprised by its substantial mutations but are confident current vaccines will be effective against it
As the Covid-19 third-wave hits, how many South Africans have had the virus already?
Increasing seroprevalence in South Africa could help curb the disastrous effects a third wave could have on communities. But no one is out of the woods yet
Slow registration delays South Africa’s vital vaccine roll-out
This has resulted in demand exceeding supply — or vice versa — at many vaccination sites
South Africa not yet in a third wave, says health department
The number of Covid-19 cases in the country has increased by an average of 46% over seven days
Johnson & Johnson vaccines could arrive in South Africa next week
We spoke to experts, looked at the data and relistened to the health department’s briefings to break down the revised roll-out plan
Jury still out on pregnant women getting a Covid jab
Few trials have been carried out on women expecting babies
Second doses of AstraZeneca vaccine are still on their way to South Africa
The department of health and experts briefed the media on Sunday, after a study showed the vaccine is not highly effective against the new variant
South Africa pauses Covid-19 vaccine rollout after disappointing AstraZeneca results
SA’s one-million doses of the AstraZeneca vaccine will expire by early April — unless India’s Serum Institute can safely extend their use-by date.
The vaccines arrive on Monday: Who will protect them and who will get them first?
The first batch of vaccines is almost here, but a top government adviser says achieving herd immunity by the end of the year is ‘unrealistic’
Vaccine trial results due in December
If successful, it will then have to be manufactured and distributed
People’s behaviour stoking Gauteng pandemic
The active case count of Gauteng surpasses that of whole countries. Workers at clinics report a ‘concerning’ relaxation of basic health protocols
Eusebius McKaiser: How do we decide whose lives matter most?
The way Covid-19 death facts are reported (age and comorbidities) reflects how old people and those with chronic conditions are valued. Scientifically there’s an argument for…